Review
doi: 10.1200/JCO.2001.19.18.3817.
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer
Affiliations
- PMID: 11559719
- DOI: 10.1200/JCO.2001.19.18.3817
Item in Clipboard
Review
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer
J Clin Oncol.
.
No abstract available
Comment in
-
Meeting highlights: International Consensus Panel on the treatment of primary breast cancer.J Clin Oncol. 2002 Feb 1;20(3):879-80. doi: 10.1200/JCO.2002.20.3.879. J Clin Oncol. 2002. PMID: 11821479 No abstract available.
-
Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer.J Clin Oncol. 2002 Apr 1;20(7):1954-5. doi: 10.1200/JCO.2002.20.7.1954. J Clin Oncol. 2002. PMID: 11919262 No abstract available.
-
Meeting highlights: International consensus panel on the treatment of primary breast cancer.J Clin Oncol. 2002 Apr 1;20(7):1955-6; author reply 1956-7. doi: 10.1200/JCO.2002.20.7.1955. J Clin Oncol. 2002. PMID: 11919263 No abstract available.
Similar articles
-
Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?J Clin Oncol. 2012 Apr 20;30(12):1384-6. doi: 10.1200/JCO.2011.40.7494. Epub 2012 Mar 5. J Clin Oncol. 2012. PMID: 22393083 Review. No abstract available.
-
[Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].Cancer Radiother. 2014 Mar;18(2):107-10. doi: 10.1016/j.canrad.2013.12.007. Epub 2014 Mar 14. Cancer Radiother. 2014. PMID: 24637020 French.
-
Update: NCCN breast cancer clinical practice guidelines.J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-1-4. J Natl Compr Canc Netw. 2004. PMID: 23570090 No abstract available.
-
Meeting highlights: international consensus panel on the treatment of primary breast cancer.J Natl Cancer Inst. 1995 Oct 4;87(19):1441-5. doi: 10.1093/jnci/87.19.1441. J Natl Cancer Inst. 1995. PMID: 7674331 No abstract available.
-
Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?BMJ. 2018 May 17;361:k1410. doi: 10.1136/bmj.k1410. BMJ. 2018. PMID: 29773535 Review. No abstract available.
Cited by
-
Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy.World J Surg Oncol. 2020 Jul 21;18(1):177. doi: 10.1186/s12957-020-01959-9. World J Surg Oncol. 2020. PMID: 32693794 Free PMC article.
-
A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.Breast Cancer. 2016 May;23(3):499-509. doi: 10.1007/s12282-015-0593-z. Epub 2015 Feb 6. Breast Cancer. 2016. PMID: 25655898 Free PMC article. Clinical Trial.
-
A prognostic index for operable, node-negative breast cancer.Br J Cancer. 2004 May 17;90(10):1933-41. doi: 10.1038/sj.bjc.6601826. Br J Cancer. 2004. PMID: 15138474 Free PMC article.
-
Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen.Br J Cancer. 2003 Jul 21;89(2):268-70. doi: 10.1038/sj.bjc.6601060. Br J Cancer. 2003. PMID: 12865915 Free PMC article. Clinical Trial.
-
Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.Curr Oncol Rep. 2003 Jan;5(1):72-7. doi: 10.1007/s11912-003-0090-y. Curr Oncol Rep. 2003. PMID: 12493154 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
